{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:26:48Z","timestamp":1790108808945,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3G1731"],"award-info":[{"award-number":["CMRPG3G1731"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG3G1732"],"award-info":[{"award-number":["CMRPG3G1732"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jmii.2021.01.007","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:52:18Z","timestamp":1613609538000},"page":"971-978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan"],"prefix":"10.1016","volume":"54","author":[{"given":"Shu-Li","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9594-8854","authenticated-orcid":false,"given":"Ting-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5581-6793","authenticated-orcid":false,"given":"Hsin-Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Yueh","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jang-Jih","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2021.01.007_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.jmii.2021.01.007_bib2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988\u20131994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib4","first-page":"402","article-title":"Clinical significance of post-treatment viral load of cytomegalovirus in patients with hematologic malignancies","volume":"52","author":"Lu","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.01.007_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jmii.2018.12.002","article-title":"The clinical features and mortality risk factors of cytomegalovirus infection in patients with systemic lupus erythematosus","volume":"52","author":"Hung","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2021.01.007_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1186\/s12879-018-3195-5","article-title":"Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis","volume":"18","author":"Li","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib7","doi-asserted-by":"crossref","first-page":"ofx029","DOI":"10.1093\/ofid\/ofx029","article-title":"Association between cytomegalovirus reactivation and clinical outcomes in immunocompetent critically ill patients: a systematic review and meta-analysis","volume":"4","author":"Lachance","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-017-0180-z","article-title":"Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation","volume":"7","author":"Styczynski","year":"2018","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jmii.2021.01.007_bib9","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fmed.2020.00188","article-title":"Cytomegalovirus: a troll in the ICU? Overview of the literature and perspectives for the future","volume":"7","author":"Schildermans","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.jmii.2021.01.007_bib10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"42","author":"Lurain","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2021.01.007_bib11","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.3390\/ijms20112666","article-title":"Cytomegalovirus infections after hematopoietic stem cell transplantation: current status and future immunotherapy","volume":"20","author":"Cho","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jmii.2021.01.007_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.jmii.2021.01.007_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/AAC.44.3.688-692.2000","article-title":"A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates","volume":"44","author":"Landry","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2021.01.007_bib14","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/QCO.0b013e32834cfb58","article-title":"The biology of cytomegalovirus drug resistance","volume":"24","author":"Hakki","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib15","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1128\/JCM.40.7.2381-2386.2002","article-title":"Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA","volume":"40","author":"Sanchez","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2021.01.007_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-0934(03)00103-4","article-title":"A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients","volume":"110","author":"Yun","year":"2003","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jmii.2021.01.007_bib17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jmv.20471","article-title":"Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis","volume":"77","author":"Boivin","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2021.01.007_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1086\/514041","article-title":"High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes","volume":"176","author":"Smith","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/MOT.0000000000000666","article-title":"Updates on antiviral drugs for cytomegalovirus prevention and treatment","volume":"24","author":"Kotton","year":"2019","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.jmii.2021.01.007_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/338362","article-title":"Cytomegalovirus UL97 phosphotransferase mutations that affect susceptibility to ganciclovir","volume":"185","author":"Chou","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/CMR.12.2.286","article-title":"Resistance of human cytomegalovirus to antiviral drugs","volume":"12","author":"Erice","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2021.01.007_bib22","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1128\/JCM.00611-13","article-title":"Rapid detection of human cytomegalovirus UL97 and UL54 mutations directly from patient samples","volume":"51","author":"Hall Sedlak","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2021.01.007_bib23","series-title":"Virual Culture; Approved Guideline. CLSI document M41-A","year":"2006"},{"key":"10.1016\/j.jmii.2021.01.007_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/BF01968138","article-title":"Detection of cytomegalovirus by the early-antigen immunofluorescence test versus conventional tissue culture","volume":"8","author":"Lautenschlager","year":"1989","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib25","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1016\/j.transproceed.2006.08.161","article-title":"Prevalence of human cytomegalovirus UL97 D605E mutation in transplant recipients in China","volume":"38","author":"Zhou","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jmii.2021.01.007_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1348-0421.2011.00327.x","article-title":"Human cytomegalovirus UL97 D605E polymorphism has a high prevalence in immunocompetent Japanese infants and children","volume":"55","author":"Tanaka","year":"2011","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.jmii.2021.01.007_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jfma.2011.08.025","article-title":"Lack of resistance-associated mutations in UL54 and UL97 genes of circulating Cytomegalovirus strains isolated in a medical center in Taiwan","volume":"111","author":"Shao","year":"2012","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jmii.2021.01.007_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jmv.20150","article-title":"Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations","volume":"74","author":"Scott","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.jmii.2021.01.007_bib29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/infdis\/163.4.716","article-title":"Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection","volume":"163","author":"Drew","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib30","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/jvi.70.3.1390-1395.1996","volume":"70","author":"Baldanti","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.jmii.2021.01.007_bib31","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1128\/AAC.49.7.2710-2715.2005","article-title":"Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene","volume":"49","author":"Chou","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2021.01.007_bib32","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcv.2003.08.010","article-title":"The influence of mixed HCMV UL97 wildtype and mutant strains on ganciclovir susceptibility in a cell associated plaque reduction assay","volume":"30","author":"Eckle","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jmii.2021.01.007_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/QCO.0b013e328307c7b4","article-title":"Update in management of ganciclovir-resistant cytomegalovirus infection","volume":"21","author":"Avery","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/cid\/cix259","article-title":"Risk factors and outcomes of ganciclovir-resistant cytomegalovirus infection in solid organ transplant recipients","volume":"65","author":"Fisher","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/bjh.12363","article-title":"Management of cytomegalovirus infection in haemopoietic stem cell transplantation","volume":"162","author":"Emery","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jmii.2021.01.007_bib36","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/jac\/dkq368","article-title":"Drug-resistant cytomegalovirus in transplant recipients: a French cohort study","volume":"65","author":"Hantz","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jmii.2021.01.007_bib37","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/514249","article-title":"Cytomegalovirus retinitis and viral resistance: ganciclovir resistance","volume":"177","author":"Jabs","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jmii.2021.01.007_bib38","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/00007890-199911150-00010","article-title":"The impact of ganciclovir-resistant cytomegalovirus infection after lung transplantation","volume":"68","author":"Kruger","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.jmii.2021.01.007_bib39","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/340312","article-title":"A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection","volume":"185","author":"Opravil","year":"2002","journal-title":"J Infect Dis"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118221000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118221000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:26:41Z","timestamp":1761658001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118221000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1684118221000220"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2021.01.007","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2021.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}